2013 Scholar-Innovators

Marc I. Diamond, MD

Washington University in St. Louis

Development of new treatments for Alzheimer’s disease and other types of dementia

Roger A. Greenberg, MD, PhD

University of Pennsylvania

Creation of a new class of drugs to prevent breast and ovarian cancer

Geoffrey S. Gurtner, MD, FACS

Stanford University

Development of a topical drug to heal wounds, particularly in people with diabetes

Richard N. Kitsis, MD

Albert Einstein College of Medicine

Creation of a first-in-class drug to reduce heart cell damage from heart attacks

Wolfgang B. Liedtke, MD, PhD

Duke University

Development of a new class of drugs that inhibit the pain response in skin

Sanford D. Markowitz, MD, PhD

Case Western Reserve University

Discovery of a compound that increases natural protective substances in tissues to help with liver regeneration and number of human diseases including pulmonary hypertension and cancer

Scott A. Oakes, MD

University of California, San Francisco

Discovery of a novel life-death switch that has led to new drugs for Lou Gehrig’s disease, diabetes, and multiple myeloma

Feroz R. Papa, MD, PhD

University of California, San Francisco

Molecular, cellular, and organismal approaches to address broad questions revolving around protein misfolding and cell degenerative diseases

Jonathan D. Powell, MD, PhD

The Johns Hopkins University

Development of a class of drugs to treat diabetes and obesity by lowering bad cholesterol and glucose and generating good fat

Larry S. Schlesinger, MD

The Ohio State University

A new class of anti-tuberculosis drugs that will prevent the development of drug resistance

2013 Scholar-Innovators

Marc I. Diamond, MD

Roger A. Greenberg, MD, PhD

Geoffrey S. Gurtner, MD, FACS

Richard N. Kitsis, MD

Wolfgang B. Liedtke, MD, PhD

Sanford D. Markowitz, MD, PhD

Scott A. Oakes, MD

Feroz R. Papa, MD, PhD

Jonathan D. Powell, MD, PhD

Larry S. Schlesinger, MD

Robert B. Wilson, MD, PhD

The Harrington Project for Discovery & Development

Discover

Advance

Commercialize

Breakthrough Medicine